Xinjuan Kong
-
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 4
-
- Hepatitis C virus research 4
- Liver Disease and Transplantation 3
-
- Circular RNAs in diseases 3
-
- Hepatitis B Virus Studies 6
- Liver Disease Diagnosis and Treatment 5
-
- Cancer Research and Treatments 4
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xinjuan Kong
28 papers receiving 512 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 159
- Hepatology 36
- Molecular Biology 304
- Geriatrics and Gerontology 17
- Periodontics 18
Countries citing papers authored by Xinjuan Kong
This map shows the geographic impact of Xinjuan Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinjuan Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinjuan Kong more than expected).
Fields of papers citing papers by Xinjuan Kong
This network shows the impact of papers produced by Xinjuan Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinjuan Kong. The network helps show where Xinjuan Kong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xinjuan Kong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 7 | |
| 3 | 2022 | 1 | |
| 4 | 2021 | 4 | |
| 5 | 2020 | 28 | |
| 6 | 2020 | 31 | |
| 7 | 2020 | 10 | |
| 8 | 2018 | 0 | |
| 9 | 2018 | 26 | |
| 10 | 2017 | 6 | |
| 11 | 2016 | 72 | |
| 12 | 2015 | 66 | |
| 13 | 2015 | 15 | |
| 14 | 2014 | 40 | |
| 15 | 2013 | 1 | |
| 16 | 2011 | 19 | |
| 17 | 2005 | 9 | |
| 18 | 2003 | 1 | |
| 19 | [Inhibition of mutant p53 in hepatocellular carcinoma cells by hammerhead ribozyme]. | 2003 | 1 |
| 20 | [Development of lamivudine-resistance microarray and its reliability in clinical examination]. | 2002 | 1 |
About Xinjuan Kong
Xinjuan Kong is a scholar working on Hepatology, Biotechnology and Cancer Research, having authored 34 papers that have together received 521 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (6 papers), MicroRNA in disease regulation (5 papers), Liver Disease Diagnosis and Treatment (5 papers), Cancer-related molecular mechanisms research (4 papers), Cancer Research and Treatments (4 papers), Hepatitis C virus research (4 papers), Liver Disease and Transplantation (3 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Cancer Research (159 citations), Hepatology (36 citations) and Molecular Biology (304 citations). Xinjuan Kong has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xue Jing, Shaoming Li, Keqian Zhi, Ling Gao, Zibin Tian, Zhen Sun, Guo Pin, Chen Jiang, Xueli Ding and Bingzi Dong. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.